---
document_datetime: 2025-11-23 08:07:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-dura.html
document_name: clopidogrel-dura.html
version: success
processing_time: 0.1024648
conversion_datetime: 2025-12-26 17:40:37.751024
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel DURA

[RSS](/en/individual-human-medicine.xml/66313)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 5 May 2015, the European Commission withdrew the marketing authorisation for Clopidogrel DURA (clopidogrel) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Mylan Dura GmbH, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Clopidogrel DURA was granted marketing authorisation in the EU on 27 July 2009 for the following indication:

- Prevention of atherothrombotic events Clopidogrel is indicated in:
    - Adults patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2014. Clopidogrel DURA is a generic medicine of Plavix. There are other generic medicinal products of Plavix authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Clopidogrel DURA is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Clopidogrel DURA : EPAR - Summary for the public

English (EN) (500.91 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 10/07/2015

[View](/en/documents/overview/clopidogrel-dura-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-54)

български (BG) (666.03 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/bg/documents/overview/clopidogrel-dura-epar-summary-public_bg.pdf)

español (ES) (502.83 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/es/documents/overview/clopidogrel-dura-epar-summary-public_es.pdf)

čeština (CS) (640.33 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/cs/documents/overview/clopidogrel-dura-epar-summary-public_cs.pdf)

dansk (DA) (502.77 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/da/documents/overview/clopidogrel-dura-epar-summary-public_da.pdf)

Deutsch (DE) (503.53 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/de/documents/overview/clopidogrel-dura-epar-summary-public_de.pdf)

eesti keel (ET) (501.87 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/et/documents/overview/clopidogrel-dura-epar-summary-public_et.pdf)

ελληνικά (EL) (676.7 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/el/documents/overview/clopidogrel-dura-epar-summary-public_el.pdf)

français (FR) (503.27 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fr/documents/overview/clopidogrel-dura-epar-summary-public_fr.pdf)

italiano (IT) (44.12 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/it/documents/overview/clopidogrel-dura-epar-summary-public_it.pdf)

latviešu valoda (LV) (640.76 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lv/documents/overview/clopidogrel-dura-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (612.64 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lt/documents/overview/clopidogrel-dura-epar-summary-public_lt.pdf)

magyar (HU) (631.46 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/hu/documents/overview/clopidogrel-dura-epar-summary-public_hu.pdf)

Malti (MT) (641.86 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/mt/documents/overview/clopidogrel-dura-epar-summary-public_mt.pdf)

Nederlands (NL) (502.6 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/nl/documents/overview/clopidogrel-dura-epar-summary-public_nl.pdf)

polski (PL) (646.38 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pl/documents/overview/clopidogrel-dura-epar-summary-public_pl.pdf)

português (PT) (502.72 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pt/documents/overview/clopidogrel-dura-epar-summary-public_pt.pdf)

română (RO) (606.6 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/ro/documents/overview/clopidogrel-dura-epar-summary-public_ro.pdf)

slovenčina (SK) (637.55 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sk/documents/overview/clopidogrel-dura-epar-summary-public_sk.pdf)

slovenščina (SL) (596.03 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sl/documents/overview/clopidogrel-dura-epar-summary-public_sl.pdf)

Suomi (FI) (501.85 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fi/documents/overview/clopidogrel-dura-epar-summary-public_fi.pdf)

svenska (SV) (502.3 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sv/documents/overview/clopidogrel-dura-epar-summary-public_sv.pdf)

## Product information

Clopidogrel DURA : EPAR - Product Information

English (EN) (807.47 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 10/07/2015

[View](/en/documents/product-information/clopidogrel-dura-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-330)

български (BG) (1.47 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/bg/documents/product-information/clopidogrel-dura-epar-product-information_bg.pdf)

español (ES) (809.59 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/es/documents/product-information/clopidogrel-dura-epar-product-information_es.pdf)

čeština (CS) (1.18 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/cs/documents/product-information/clopidogrel-dura-epar-product-information_cs.pdf)

dansk (DA) (735.62 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/da/documents/product-information/clopidogrel-dura-epar-product-information_da.pdf)

Deutsch (DE) (735.69 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/de/documents/product-information/clopidogrel-dura-epar-product-information_de.pdf)

eesti keel (ET) (745.43 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/et/documents/product-information/clopidogrel-dura-epar-product-information_et.pdf)

ελληνικά (EL) (1.59 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/el/documents/product-information/clopidogrel-dura-epar-product-information_el.pdf)

français (FR) (767.22 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fr/documents/product-information/clopidogrel-dura-epar-product-information_fr.pdf)

hrvatski (HR) (808.15 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/hr/documents/product-information/clopidogrel-dura-epar-product-information_hr.pdf)

íslenska (IS) (1.28 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/is/documents/product-information/clopidogrel-dura-epar-product-information_is.pdf)

italiano (IT) (784.52 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/it/documents/product-information/clopidogrel-dura-epar-product-information_it.pdf)

latviešu valoda (LV) (1.25 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lv/documents/product-information/clopidogrel-dura-epar-product-information_lv.pdf)

lietuvių kalba (LT) (844.95 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lt/documents/product-information/clopidogrel-dura-epar-product-information_lt.pdf)

magyar (HU) (1.2 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/hu/documents/product-information/clopidogrel-dura-epar-product-information_hu.pdf)

Malti (MT) (1.17 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/mt/documents/product-information/clopidogrel-dura-epar-product-information_mt.pdf)

Nederlands (NL) (797.49 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/nl/documents/product-information/clopidogrel-dura-epar-product-information_nl.pdf)

norsk (NO) (1.26 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/no/documents/product-information/clopidogrel-dura-epar-product-information_no.pdf)

polski (PL) (1.21 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pl/documents/product-information/clopidogrel-dura-epar-product-information_pl.pdf)

português (PT) (758.64 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pt/documents/product-information/clopidogrel-dura-epar-product-information_pt.pdf)

română (RO) (910.9 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/ro/documents/product-information/clopidogrel-dura-epar-product-information_ro.pdf)

slovenčina (SK) (1.16 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sk/documents/product-information/clopidogrel-dura-epar-product-information_sk.pdf)

slovenščina (SL) (1.1 MB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sl/documents/product-information/clopidogrel-dura-epar-product-information_sl.pdf)

Suomi (FI) (749.08 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fi/documents/product-information/clopidogrel-dura-epar-product-information_fi.pdf)

svenska (SV) (761.91 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sv/documents/product-information/clopidogrel-dura-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** R/0017 05/05/2015

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel DURA : EPAR - All Authorised presentations

English (EN) (480.5 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 10/07/2015

[View](/en/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-280)

български (BG) (552.25 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/bg/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_bg.pdf)

español (ES) (468.04 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/es/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_es.pdf)

čeština (CS) (505.21 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/cs/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (464.31 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/da/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (463.9 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/de/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (468.06 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/et/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (551.22 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/el/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_el.pdf)

français (FR) (467.73 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fr/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (467.26 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/it/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (562.34 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lv/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (535.75 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/lt/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (547.89 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/hu/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (544.46 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/mt/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (465.85 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/nl/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_nl.pdf)

polski (PL) (510.52 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pl/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_pl.pdf)

português (PT) (483.58 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/pt/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_pt.pdf)

română (RO) (531.12 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/ro/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (524.92 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sk/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (480.14 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sl/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (467.29 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/fi/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (483.56 KB - PDF)

**First published:**

14/10/2009

**Last updated:**

10/07/2015

[View](/sv/documents/all-authorised-presentations/clopidogrel-dura-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel DURA Active substance clopidogrel (as hydrochloride) International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Stroke
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

## Authorisation details

EMA product number EMEA/H/C/001132

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Mylan dura GmbH

Wittichstraße 6

Marketing authorisation issued 21/07/2009 Withdrawal of marketing authorisation 05/05/2015 Revision 6

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel DURA : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (594.33 KB - PDF)

**First published:** 30/03/2010

**Last updated:** 10/07/2015

[View](/en/documents/procedural-steps-after/clopidogrel-dura-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Clopidogrel DURA : EPAR - Public assessment report

English (EN) (780.42 KB - PDF)

**First published:** 14/10/2009

**Last updated:** 10/07/2015

[View](/en/documents/assessment-report/clopidogrel-dura-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Clopidogrel DURA

Reference Number: EMEA/CHMP/379512/2009

English (EN) (488.41 KB - PDF)

**First published:** 25/06/2009

**Last updated:** 10/07/2015

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-clopidogrel-dura_en.pdf)

**This page was last updated on** 10/07/2015

## Share this page

[Back to top](#main-content)